Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.20.2
Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2020
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following as of September 30, 2020 and December 31, 2019 (in thousands):

 

 

 

September 30, 2020

 

 

December 31, 2019

 

External research and preclinical development

 

$

5,651

 

 

$

5,395

 

Employee compensation and benefits

 

 

3,924

 

 

 

4,174

 

Professional fees

 

 

667

 

 

 

694

 

Facilities and other

 

 

43

 

 

 

383

 

 

 

$

10,285

 

 

$

10,646